MedPath

Comparison of hyperbaric ropivacaine and hyperbaric bupivacaine for spinal anaesthesia in anorectal and urological surgeries

Phase 3
Conditions
Health Condition 1: N471- PhimosisHealth Condition 2: N359- Urethral stricture, unspecifiedHealth Condition 3: N20-N23- Urolithiasis
Registration Number
CTRI/2023/05/052486
Lead Sponsor
Sneha T
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients scheduled to undergo elective anorectal and urological surgeries under spinal anaesthesia

2.Patients of ASA physical status I & II.

3.Patients of either sex.

4.Age >18 years or < 60 years

Exclusion Criteria

1.Patients of ASA physical status III and IV

2.Patients with local site infection, allergy to the drugs used

3.Patients who have psychiatric illness, coagulation abnormalities

4.Pregnant / Lactating women.

5.Patients refusal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) duration of motor blockade <br/ ><br>Timepoint: 1) time from intrathecal injection to modified bromage score 0
Secondary Outcome Measures
NameTimeMethod
1) onset and duration of sensory block <br/ ><br>2) pain assessmentTimepoint: 1) pin prick assessed every minute from 1min to 6 mins and then every 10 mins until two segment regression <br/ ><br>2) VAS score postoveratively
© Copyright 2025. All Rights Reserved by MedPath